On the possibility of using hyaluronic acid in a composition with rhenium-188 for radiosynoviorthesis

Introduction. Osteoarthritis is one of the most common joint diseases. The number of patients is growing rapidly and by 2050, the number of people in the world suffering from osteoarthritis is expected to exceed 1 billion. In a number of European countries, radiosynoviorthesis is used as a treatment...

Full description

Bibliographic Details

Published in:	Разработка и регистрация лекарственных средств
Main Authors:	K. V. Mayorov, N. D. Beloglazova, N. G. Sashova, G. E. Kodina, A. O. Malysheva, O. E. Klementyeva
Format:	Article
Language:	Russian
Published:	LLC Center of Pharmaceutical Analytics (LLC «CPHA») 2025-06-01
Subjects:	nuclear medicine radiopharmaceuticals rhenium-188 radionuclide generator hyaluronic acid radiosynoviorthesis osteoarthritis radiochemical purity
Online Access:	https://www.pharmjournal.ru/jour/article/view/2067